Global Mammalian Transient Protein Market revenues are projected to surpass US$ 641.0 Mn in 2022, likely to surge at a vigorous 9.0% CAGR during the assessment period according to a new study by Future Market Insights (FMI). The report also states that innovations in automation and recombinant proteins will support market developments, however, prohibitive costs and the complexity to maintain media purity remain challenges.
Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12807
Key Takeaways on Mammalian Transient Protein Expression Market
- The size of the mammalian transient protein expression market is estimated to reach approximately US$ 540 Mn by the end of 2020, with antibody and therapeutic protein production applications being the primary factors driving growth in the industry.
- Biopharmaceutical companies will remain prominent end-users of mammalian transient protein expression, while CROs are also likely to reflect steady growth on the back of biologics and drug development endeavours.
- Chinese hamster ovary cells in terms of cell lines reflect relatively higher demand, owing to applications in academic and research uses, accounting for ~70% of market share by 2030.
- North America followed by Europe are leading markets for mammalian transient protein expression, access to cutting edge healthcare technologies, and the presence of leading market players.
Covid-19 Impact on Mammalian Transient Protein Expression Market
The Impact of the covid-19 pandemic on the mammalian transient protein expression market has largely been negative. Strict lockdown and social distancing regulations have resulted in delayed projects in research and biomedicine applications.
Also, market players have witnessed lower sales and revenue during the crisis period arising from supply chain disruptions, and a shortage of adequate manpower. On the other hand, the potential for applications in vaccine development is likely to provide opportunities for short-term growth, moderately mitigating loss during this period.
Leading Companies Profiled in Mammalian Transient Protein Expression Market are
- Thermofisher Scientific
- Merck KGaA
- Promega Corporation
- Lonza
- Agilent Technologies, Inc.
- Bio-Rad
- Qiagen
- Takara Bio
- HiMedia Laboratories.
- Mirus
- Sino Biological, Inc.
Request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-12807
Who is Winning?
In its latest report, Future Market Insights has provided details on key business strategies that are gaining importance in the mammalian transient protein expression market. Market leaders in the industry have been pushing for the expansion of their portfolios with offerings associated with antibody development and gene coding. Also, strategic collaborations are gaining ground in the sector.
Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc., Qiagen N.V., and Bio-Rad Laboratories Inc., are some of the key companies operating in the mammalian transient protein expression market.
Key Market Segments Covered in Mammalian Transient Protein Expression Industry Research
By Product:
- Instruments
- Expression Vector
- Reagents & Consumables
- Cell Lines
- Chinese Hamster Ovary Cells (CHO)
- Human embryonic kidney 293 (HEK 293) cells
- Others
By Application:
- Bio-productio
- Antibody Production
- Therapeutic protein production
- Functional Cell-Based Assays
- Academic Research
- Others
By End-User:
- Contract Research Organization
- Biopharmaceutical Companies
- Academic & Research Institutes
Get Customization on this Report for Specific Country@ https://www.futuremarketinsights.com/customization-available/rep-gb-12807
Why Future Market Insights?
- Comprehensive analysis of evolving purchase patterns across different geographies
- Detailed insights of market segments and sub-segments for historical as well as the forecast period
- A competitive analysis of prominent players and emerging players in the keyword market
- Detailed information about the product innovation, mergers and acquisitions lined up in upcoming Groundbreaking research and market player-centric solutions for the upcoming decade according to the present market scenario
Explore wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape
Automated Suturing Devices Market:- ESOMAR-certified consulting firm Future Market Insight (FMI) presents incisive global Automated Suturing Devices Market survey for the forecast period of 2021-2031. According to the report, the market is expected to expand, rising at a CAGR of 7.3 % during the forecast period.
Dental Imaging Equipment Market:- Future Market Insights’ recently published report on the Dental Imaging Equipment Market predicts that growth is expected to accelerate at a positive 7.9% CAGR during the forecast period of 2022-2030.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs